Mylan Faces Scrutiny Over EpiPen Price Increases

August 24, 2016 9:41 PM

12 0

Mylan Faces Scrutiny Over EpiPen Price Increases

Criticisms mount after drugmaker raises cost of allergy treatment by 548% since 2007

Mylan MYL -5.41 % NV became the latest pharmaceutical company to face popular outrage about higher drug costs, as attacks mounted Wednesday on the company’s substantial price increases for the EpiPen emergency allergy treatment.

Also read: Trump warns Wall Street: I'm going to cut drug prices

Read more

To category page

Loading...